Skip to main content
. 2016 Dec 10;8(4):6341–6352. doi: 10.18632/oncotarget.13856

Table 2. Combination activity of melflufen and cytarabine or daunorubicin in HL-60 for selected concentrations (calculated according to the multiplicative Bliss model).

Concentrationmelflufen(μM) Concentrationcytarabine(μM) Concentrationdaunorubicin(μM) PI melflufen(%) PIcytarabine(%) PIcombination(%) PIcombinationpredicted Interaction
0.030 0.25 NA 47 30 71 63 S
0.030 0.50 NA 47 45 83 71 S
0.063 0.25 NA 71 30 83 79 S
0.063 0.50 NA 71 45 88 84 S
0.030 NA 0.013 47 40 54 68 SA
0.030 NA 0.025 47 58 71 77 SA
0.063 NA 0.013 71 40 74 83 SA
0.063 NA 0.025 71 58 78 88 SA

Abbreviations: PI; percent inhibition, S; Synergy, SA; Subadditive interaction.